Chondrocyte therapeutic delivery system
US8153117B2 · kind B2 · utility
4Cited by
67References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2006 |
| Grant date | Apr 10, 2012 |
| Priority date | — |
| Expiry date | Nov 17, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for producing therapeutic agents using chondrocytes are provided. The genetically engineered chondrocytes can be used to express the therapeutic agent in a subject, including in an environment typically associated with chondrocytes and in an environment not typically associated with chondrocytes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.